MedPath

Effect of alkaline water on bone health

Phase 2
Conditions
osteoporosis.
Osteoporosis with current pathological fracture
Registration Number
IRCT20170929036477N3
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Postmenopausal women
Having at least 12 months of menstruation pause
and osteoporosis
Prone to osteoporesis with T score of less than 2.5 in bone density measurement

Exclusion Criteria

Pregnancy
Breastfeeding
Smoking
Drinking alcohol
Other hormonal disorders
Use hormones or drugs with negative or positive effect on bone metabolism (such as, estrogens and bisphosphates) in the past year
Involuntary participating in the study
Allergy to drugs
Certain complications such as hallucinations, confusion and numbness
Nausea, vomiting,
Restlessness
Seizure
Disorders of intestinal absorption
Thyroid, kidney or liver disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
T score. Timepoint: At the beginning of the study and 3 months later. Method of measurement: Bone densitometry.
Secondary Outcome Measures
NameTimeMethod
Bone density. Timepoint: At first visit and then 3 months after start of intevention. Method of measurement: Bone Densitometry.
© Copyright 2025. All Rights Reserved by MedPath